

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.70531048 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.49047296 |
| 3 | axonemal dynein complex assembly (GO:0070286) | 5.43266364 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.23823552 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.23046943 |
| 6 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.16709973 |
| 7 | cilium movement (GO:0003341) | 5.16647509 |
| 8 | epithelial cilium movement (GO:0003351) | 5.16065622 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.98376976 |
| 10 | vocalization behavior (GO:0071625) | 4.88142123 |
| 11 | protein localization to synapse (GO:0035418) | 4.73551680 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.65334131 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.61115061 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.52294468 |
| 15 | glutamate secretion (GO:0014047) | 4.47937469 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.45766947 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.31403623 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.28083066 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.21223115 |
| 20 | exploration behavior (GO:0035640) | 3.99105043 |
| 21 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.96358376 |
| 22 | axoneme assembly (GO:0035082) | 3.95684450 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.95371108 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.93941983 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.91156145 |
| 26 | motile cilium assembly (GO:0044458) | 3.89542288 |
| 27 | neurotransmitter secretion (GO:0007269) | 3.85143202 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 3.82545994 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 3.82455326 |
| 30 | layer formation in cerebral cortex (GO:0021819) | 3.82000563 |
| 31 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.76761536 |
| 32 | glutamate receptor signaling pathway (GO:0007215) | 3.75018321 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.62606941 |
| 34 | neuron recognition (GO:0008038) | 3.61055120 |
| 35 | neuronal action potential propagation (GO:0019227) | 3.58134441 |
| 36 | regulation of cilium movement (GO:0003352) | 3.56563761 |
| 37 | intraciliary transport (GO:0042073) | 3.53196506 |
| 38 | cellular potassium ion homeostasis (GO:0030007) | 3.52111339 |
| 39 | transmission of nerve impulse (GO:0019226) | 3.50200897 |
| 40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.48816961 |
| 41 | positive regulation of membrane potential (GO:0045838) | 3.47335246 |
| 42 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.46880777 |
| 43 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.44854559 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.41862341 |
| 45 | long-term memory (GO:0007616) | 3.41569779 |
| 46 | positive regulation of neurotransmitter transport (GO:0051590) | 3.40450182 |
| 47 | regulation of synapse structural plasticity (GO:0051823) | 3.40401937 |
| 48 | retinal cone cell development (GO:0046549) | 3.40113420 |
| 49 | regulation of postsynaptic membrane potential (GO:0060078) | 3.38387930 |
| 50 | axonal fasciculation (GO:0007413) | 3.38069487 |
| 51 | synaptic vesicle endocytosis (GO:0048488) | 3.35065575 |
| 52 | regulation of neurotransmitter secretion (GO:0046928) | 3.33929740 |
| 53 | startle response (GO:0001964) | 3.33615266 |
| 54 | neurotransmitter transport (GO:0006836) | 3.31198508 |
| 55 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.28145557 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.27630751 |
| 57 | left/right pattern formation (GO:0060972) | 3.27326093 |
| 58 | long-term synaptic potentiation (GO:0060291) | 3.26048047 |
| 59 | protein localization to cilium (GO:0061512) | 3.25802786 |
| 60 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.24892692 |
| 61 | proline transport (GO:0015824) | 3.17540148 |
| 62 | membrane hyperpolarization (GO:0060081) | 3.17401813 |
| 63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.17393778 |
| 64 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.12788563 |
| 65 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.12760970 |
| 66 | postsynaptic membrane organization (GO:0001941) | 3.12432683 |
| 67 | * cilium organization (GO:0044782) | 3.11380670 |
| 68 | regulation of synaptic plasticity (GO:0048167) | 3.10740298 |
| 69 | regulation of vesicle fusion (GO:0031338) | 3.09727538 |
| 70 | * cilium assembly (GO:0042384) | 3.09547684 |
| 71 | auditory behavior (GO:0031223) | 3.07488114 |
| 72 | dendrite morphogenesis (GO:0048813) | 3.06615066 |
| 73 | nucleobase catabolic process (GO:0046113) | 3.05063887 |
| 74 | innervation (GO:0060384) | 3.04260577 |
| 75 | regulation of neurotransmitter transport (GO:0051588) | 3.03223526 |
| 76 | protein polyglutamylation (GO:0018095) | 3.03075363 |
| 77 | cell migration in hindbrain (GO:0021535) | 3.02924019 |
| 78 | rhodopsin mediated signaling pathway (GO:0016056) | 3.01460530 |
| 79 | calcium ion-dependent exocytosis (GO:0017156) | 3.01014975 |
| 80 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.00707492 |
| 81 | central nervous system myelination (GO:0022010) | 2.99847655 |
| 82 | axon ensheathment in central nervous system (GO:0032291) | 2.99847655 |
| 83 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.99567873 |
| 84 | sodium ion export (GO:0071436) | 2.98292955 |
| 85 | urinary tract smooth muscle contraction (GO:0014848) | 2.98103736 |
| 86 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.96535889 |
| 87 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96512059 |
| 88 | presynaptic membrane organization (GO:0097090) | 2.96374302 |
| 89 | response to auditory stimulus (GO:0010996) | 2.96138712 |
| 90 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.95980556 |
| 91 | chemosensory behavior (GO:0007635) | 2.95943186 |
| 92 | neuromuscular process controlling balance (GO:0050885) | 2.93306780 |
| 93 | cilium morphogenesis (GO:0060271) | 2.93296440 |
| 94 | learning (GO:0007612) | 2.92873854 |
| 95 | vesicle transport along microtubule (GO:0047496) | 2.90801967 |
| 96 | positive regulation of synapse maturation (GO:0090129) | 2.90249485 |
| 97 | membrane depolarization (GO:0051899) | 2.89615009 |
| 98 | membrane depolarization during action potential (GO:0086010) | 2.88923176 |
| 99 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.88129214 |
| 100 | regulation of microtubule-based movement (GO:0060632) | 2.87868136 |
| 101 | prepulse inhibition (GO:0060134) | 2.87854594 |
| 102 | regulation of neurotransmitter levels (GO:0001505) | 2.87708572 |
| 103 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.86937908 |
| 104 | response to histamine (GO:0034776) | 2.86542904 |
| 105 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.86487489 |
| 106 | L-amino acid import (GO:0043092) | 2.85843010 |
| 107 | activation of protein kinase A activity (GO:0034199) | 2.84811778 |
| 108 | synapse assembly (GO:0007416) | 2.84328095 |
| 109 | behavioral defense response (GO:0002209) | 2.84161226 |
| 110 | behavioral fear response (GO:0001662) | 2.84161226 |
| 111 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.82184097 |
| 112 | positive regulation of synaptic transmission (GO:0050806) | 2.78937942 |
| 113 | striatum development (GO:0021756) | 2.78899295 |
| 114 | regulation of respiratory system process (GO:0044065) | 2.78779227 |
| 115 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.78663188 |
| 116 | neuronal ion channel clustering (GO:0045161) | 2.76581510 |
| 117 | glycine transport (GO:0015816) | 2.75660630 |
| 118 | microtubule bundle formation (GO:0001578) | 2.75531481 |
| 119 | behavioral response to cocaine (GO:0048148) | 2.75400209 |
| 120 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.73312280 |
| 121 | synapse organization (GO:0050808) | 2.72280330 |
| 122 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.71138325 |
| 123 | dendritic spine organization (GO:0097061) | 2.70116337 |
| 124 | sperm motility (GO:0030317) | 2.63276155 |
| 125 | neuromuscular synaptic transmission (GO:0007274) | 2.61556133 |
| 126 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.57459972 |
| 127 | * cellular component assembly involved in morphogenesis (GO:0010927) | 2.56955969 |
| 128 | * nonmotile primary cilium assembly (GO:0035058) | 2.56856410 |
| 129 | ventricular system development (GO:0021591) | 2.55819844 |
| 130 | behavioral response to nicotine (GO:0035095) | 2.53779633 |
| 131 | limb development (GO:0060173) | 2.53199291 |
| 132 | appendage development (GO:0048736) | 2.53199291 |
| 133 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.47882558 |
| 134 | neurotransmitter catabolic process (GO:0042135) | 2.38328177 |
| 135 | smoothened signaling pathway (GO:0007224) | 2.35788604 |
| 136 | microtubule-based movement (GO:0007018) | 2.35260494 |
| 137 | short-term memory (GO:0007614) | 2.32733945 |
| 138 | retinal ganglion cell axon guidance (GO:0031290) | 2.31995074 |
| 139 | glycosphingolipid biosynthetic process (GO:0006688) | 2.31194948 |
| 140 | establishment of mitochondrion localization (GO:0051654) | 2.29828323 |
| 141 | lung epithelium development (GO:0060428) | 2.26746406 |
| 142 | regulation of respiratory gaseous exchange (GO:0043576) | 2.25289806 |
| 143 | positive regulation of synapse assembly (GO:0051965) | 2.25182718 |
| 144 | positive regulation of dendrite development (GO:1900006) | 2.24014827 |
| 145 | nephron epithelium morphogenesis (GO:0072088) | 2.20766681 |
| 146 | nephron tubule morphogenesis (GO:0072078) | 2.20766681 |
| 147 | left/right axis specification (GO:0070986) | 2.18764050 |
| 148 | mechanosensory behavior (GO:0007638) | 2.18669006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.80403892 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.59616460 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82886919 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.73293313 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71259794 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.48749561 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.44265426 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.44265426 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39656409 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36505409 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35511485 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34524389 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33459248 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.30753501 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30409708 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.18175056 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.15009630 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.13953808 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13903898 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.13562447 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12473473 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08326464 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04897268 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95992016 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94607178 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.92037630 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86028449 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.78360441 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73168376 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68423662 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67610438 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66630917 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66196074 |
| 34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.63418299 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.58979152 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57914785 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56954812 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49366339 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46249376 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43770963 |
| 41 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.43050978 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40879943 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38783734 |
| 44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38128377 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38128019 |
| 46 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.34680597 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34145657 |
| 48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31631186 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30443123 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28790653 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27209489 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26155452 |
| 53 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25327707 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24981990 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24628938 |
| 56 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24452804 |
| 57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23573739 |
| 58 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22077696 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21831520 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20193980 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20037495 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19914583 |
| 63 | AR_19668381_ChIP-Seq_PC3_Human | 1.18815517 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18606786 |
| 65 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.18406400 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18323352 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18000770 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16846984 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.16624589 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16365367 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15501319 |
| 72 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15349983 |
| 73 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14490271 |
| 74 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.14361962 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13061537 |
| 76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11734078 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11037646 |
| 78 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11037646 |
| 79 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10032185 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09265404 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09033129 |
| 82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07250617 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05589004 |
| 84 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04795374 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04785842 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04053739 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03721920 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03574282 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03367723 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02932355 |
| 91 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02613132 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01004030 |
| 93 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01004030 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00965319 |
| 95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00256322 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99676054 |
| 97 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99493429 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98387925 |
| 99 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98111800 |
| 100 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97560652 |
| 101 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96761239 |
| 102 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96320859 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95202458 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94802419 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94080971 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93442982 |
| 107 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93339431 |
| 108 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91469372 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90798692 |
| 110 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.89551211 |
| 111 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89464763 |
| 112 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89354086 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89136628 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88720919 |
| 115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87926806 |
| 116 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86778209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.51779445 |
| 2 | MP0003880_abnormal_central_pattern | 4.43345474 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.72311725 |
| 4 | MP0004270_analgesia | 3.33439033 |
| 5 | MP0009745_abnormal_behavioral_response | 3.10074058 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.00446025 |
| 7 | MP0009046_muscle_twitch | 2.95922445 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.91284887 |
| 9 | MP0002064_seizures | 2.86224952 |
| 10 | * MP0005551_abnormal_eye_electrophysiolog | 2.74741362 |
| 11 | MP0001486_abnormal_startle_reflex | 2.61083568 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.57320168 |
| 13 | * MP0002572_abnormal_emotion/affect_behav | 2.55580871 |
| 14 | MP0002272_abnormal_nervous_system | 2.36702692 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.34819076 |
| 16 | MP0002822_catalepsy | 2.12354404 |
| 17 | MP0000778_abnormal_nervous_system | 2.07426016 |
| 18 | * MP0001984_abnormal_olfaction | 2.00286621 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 1.95427201 |
| 20 | MP0001501_abnormal_sleep_pattern | 1.92359758 |
| 21 | MP0005646_abnormal_pituitary_gland | 1.89998256 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.86676493 |
| 23 | MP0005253_abnormal_eye_physiology | 1.85808862 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.85469755 |
| 25 | MP0003136_yellow_coat_color | 1.85456850 |
| 26 | MP0000566_synostosis | 1.85049867 |
| 27 | MP0002736_abnormal_nociception_after | 1.83130656 |
| 28 | MP0002184_abnormal_innervation | 1.82752045 |
| 29 | MP0004133_heterotaxia | 1.79936622 |
| 30 | * MP0002557_abnormal_social/conspecific_i | 1.78884605 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.71623694 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.70964506 |
| 33 | MP0004885_abnormal_endolymph | 1.68977333 |
| 34 | * MP0002882_abnormal_neuron_morphology | 1.66658140 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.65735098 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.64853553 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.63722505 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.61431693 |
| 39 | MP0003878_abnormal_ear_physiology | 1.61431693 |
| 40 | MP0004811_abnormal_neuron_physiology | 1.58674447 |
| 41 | MP0008569_lethality_at_weaning | 1.58544905 |
| 42 | MP0001970_abnormal_pain_threshold | 1.58189459 |
| 43 | MP0000955_abnormal_spinal_cord | 1.55111590 |
| 44 | MP0001502_abnormal_circadian_rhythm | 1.54914329 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.54066762 |
| 46 | MP0003787_abnormal_imprinting | 1.47583580 |
| 47 | MP0004924_abnormal_behavior | 1.44084282 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.44084282 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.42109916 |
| 50 | MP0003879_abnormal_hair_cell | 1.41049333 |
| 51 | MP0000631_abnormal_neuroendocrine_gland | 1.38283725 |
| 52 | MP0005410_abnormal_fertilization | 1.37159482 |
| 53 | MP0003122_maternal_imprinting | 1.34725068 |
| 54 | * MP0002066_abnormal_motor_capabilities/c | 1.34340604 |
| 55 | MP0002229_neurodegeneration | 1.31954136 |
| 56 | MP0004858_abnormal_nervous_system | 1.30008712 |
| 57 | * MP0002752_abnormal_somatic_nervous | 1.27429346 |
| 58 | MP0003011_delayed_dark_adaptation | 1.27284212 |
| 59 | * MP0002152_abnormal_brain_morphology | 1.26926240 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.26459204 |
| 61 | MP0001188_hyperpigmentation | 1.25213205 |
| 62 | MP0003329_amyloid_beta_deposits | 1.20746734 |
| 63 | MP0001905_abnormal_dopamine_level | 1.20600061 |
| 64 | MP0003283_abnormal_digestive_organ | 1.17376757 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.13119493 |
| 66 | * MP0005499_abnormal_olfactory_system | 1.12600459 |
| 67 | * MP0005394_taste/olfaction_phenotype | 1.12600459 |
| 68 | MP0003633_abnormal_nervous_system | 1.10894599 |
| 69 | * MP0005195_abnormal_posterior_eye | 1.09898691 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.09386939 |
| 71 | MP0002249_abnormal_larynx_morphology | 1.09178995 |
| 72 | MP0002090_abnormal_vision | 1.09055857 |
| 73 | MP0001529_abnormal_vocalization | 1.08769098 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.07022490 |
| 75 | MP0001963_abnormal_hearing_physiology | 1.04646361 |
| 76 | MP0002928_abnormal_bile_duct | 1.03354649 |
| 77 | MP0002234_abnormal_pharynx_morphology | 1.03250458 |
| 78 | MP0003938_abnormal_ear_development | 1.03136124 |
| 79 | MP0004742_abnormal_vestibular_system | 1.01213202 |
| 80 | MP0004142_abnormal_muscle_tone | 0.98779240 |
| 81 | MP0003634_abnormal_glial_cell | 0.98035792 |
| 82 | MP0005409_darkened_coat_color | 0.98006072 |
| 83 | MP0003631_nervous_system_phenotype | 0.97914603 |
| 84 | MP0005623_abnormal_meninges_morphology | 0.96606583 |
| 85 | MP0002282_abnormal_trachea_morphology | 0.95988763 |
| 86 | MP0005248_abnormal_Harderian_gland | 0.95487840 |
| 87 | MP0006292_abnormal_olfactory_placode | 0.91515475 |
| 88 | MP0003690_abnormal_glial_cell | 0.91107791 |
| 89 | MP0000049_abnormal_middle_ear | 0.90791720 |
| 90 | MP0002102_abnormal_ear_morphology | 0.90241332 |
| 91 | MP0008877_abnormal_DNA_methylation | 0.89821371 |
| 92 | MP0001485_abnormal_pinna_reflex | 0.89679770 |
| 93 | MP0005503_abnormal_tendon_morphology | 0.87882404 |
| 94 | MP0010030_abnormal_orbit_morphology | 0.87586444 |
| 95 | MP0000383_abnormal_hair_follicle | 0.87171642 |
| 96 | * MP0002069_abnormal_eating/drinking_beha | 0.86738721 |
| 97 | MP0000920_abnormal_myelination | 0.86130806 |
| 98 | MP0003861_abnormal_nervous_system | 0.84485825 |
| 99 | MP0001177_atelectasis | 0.83687607 |
| 100 | MP0004233_abnormal_muscle_weight | 0.82535730 |
| 101 | * MP0000026_abnormal_inner_ear | 0.80689240 |
| 102 | MP0003942_abnormal_urinary_system | 0.78130172 |
| 103 | MP0005391_vision/eye_phenotype | 0.78001180 |
| 104 | MP0008995_early_reproductive_senescence | 0.77298465 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.75153219 |
| 106 | MP0001299_abnormal_eye_distance/ | 0.74791171 |
| 107 | * MP0003698_abnormal_male_reproductive | 0.74493796 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.72680081 |
| 109 | MP0004043_abnormal_pH_regulation | 0.70905229 |
| 110 | MP0003632_abnormal_nervous_system | 0.70711473 |
| 111 | MP0005187_abnormal_penis_morphology | 0.70299116 |
| 112 | * MP0004085_abnormal_heartbeat | 0.69851490 |
| 113 | MP0004145_abnormal_muscle_electrophysio | 0.67287185 |
| 114 | MP0005171_absent_coat_pigmentation | 0.64248154 |
| 115 | MP0000751_myopathy | 0.63088153 |
| 116 | MP0003121_genomic_imprinting | 0.61960975 |
| 117 | * MP0002653_abnormal_ependyma_morphology | 0.59874180 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.59530978 |
| 119 | MP0001943_abnormal_respiration | 0.56230342 |
| 120 | MP0008874_decreased_physiological_sensi | 0.55689210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.70965872 |
| 2 | Myokymia (HP:0002411) | 4.52519754 |
| 3 | Focal seizures (HP:0007359) | 4.43589765 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.12842133 |
| 5 | Congenital stationary night blindness (HP:0007642) | 4.07329065 |
| 6 | Nephronophthisis (HP:0000090) | 4.04320383 |
| 7 | True hermaphroditism (HP:0010459) | 3.92493950 |
| 8 | Visual hallucinations (HP:0002367) | 3.89025694 |
| 9 | Abnormality of midbrain morphology (HP:0002418) | 3.87345349 |
| 10 | Molar tooth sign on MRI (HP:0002419) | 3.87345349 |
| 11 | Febrile seizures (HP:0002373) | 3.85712933 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.78232780 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.70440968 |
| 14 | Pancreatic cysts (HP:0001737) | 3.58624798 |
| 15 | Cystic liver disease (HP:0006706) | 3.48142123 |
| 16 | Central scotoma (HP:0000603) | 3.42344478 |
| 17 | Atonic seizures (HP:0010819) | 3.40988869 |
| 18 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.35846791 |
| 19 | Absent/shortened dynein arms (HP:0200106) | 3.35846791 |
| 20 | Abnormality of macular pigmentation (HP:0008002) | 3.33792773 |
| 21 | Abnormality of the renal medulla (HP:0100957) | 3.32770630 |
| 22 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.31976775 |
| 23 | Occipital encephalocele (HP:0002085) | 3.24591915 |
| 24 | Absence seizures (HP:0002121) | 3.14128306 |
| 25 | Broad-based gait (HP:0002136) | 3.13659003 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 3.10287505 |
| 27 | Action tremor (HP:0002345) | 3.03540831 |
| 28 | Abnormal drinking behavior (HP:0030082) | 3.02661542 |
| 29 | Polydipsia (HP:0001959) | 3.02661542 |
| 30 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.96401861 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 2.93423104 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 2.93390478 |
| 33 | Dyschromatopsia (HP:0007641) | 2.93060863 |
| 34 | Hyperventilation (HP:0002883) | 2.87133006 |
| 35 | Dialeptic seizures (HP:0011146) | 2.81705541 |
| 36 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.78932467 |
| 37 | Scotoma (HP:0000575) | 2.76801878 |
| 38 | Neurofibrillary tangles (HP:0002185) | 2.74612174 |
| 39 | Chronic hepatic failure (HP:0100626) | 2.71708366 |
| 40 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.68977016 |
| 41 | Truncal ataxia (HP:0002078) | 2.68257737 |
| 42 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.68159823 |
| 43 | Abnormal ciliary motility (HP:0012262) | 2.66352981 |
| 44 | Dysdiadochokinesis (HP:0002075) | 2.65740185 |
| 45 | Postaxial foot polydactyly (HP:0001830) | 2.64658696 |
| 46 | Ankle clonus (HP:0011448) | 2.60019901 |
| 47 | Depression (HP:0000716) | 2.56789023 |
| 48 | Tubular atrophy (HP:0000092) | 2.56636604 |
| 49 | Polyphagia (HP:0002591) | 2.53655785 |
| 50 | Type II lissencephaly (HP:0007260) | 2.53621568 |
| 51 | Protruding tongue (HP:0010808) | 2.52077547 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.50098212 |
| 53 | * Gait imbalance (HP:0002141) | 2.48806917 |
| 54 | Chronic bronchitis (HP:0004469) | 2.48409626 |
| 55 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.47439249 |
| 56 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.47439249 |
| 57 | Hemiparesis (HP:0001269) | 2.46650666 |
| 58 | Decreased central vision (HP:0007663) | 2.44793211 |
| 59 | Pendular nystagmus (HP:0012043) | 2.44721256 |
| 60 | Genetic anticipation (HP:0003743) | 2.42464794 |
| 61 | Congenital hepatic fibrosis (HP:0002612) | 2.42140258 |
| 62 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.39512596 |
| 63 | Infertility (HP:0000789) | 2.38927509 |
| 64 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.37295019 |
| 65 | Poor eye contact (HP:0000817) | 2.36028946 |
| 66 | Polyuria (HP:0000103) | 2.33252211 |
| 67 | Anxiety (HP:0000739) | 2.31833298 |
| 68 | Failure to thrive in infancy (HP:0001531) | 2.31739933 |
| 69 | Impaired smooth pursuit (HP:0007772) | 2.31096108 |
| 70 | Bronchiectasis (HP:0002110) | 2.29951299 |
| 71 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.29329403 |
| 72 | Dysmetria (HP:0001310) | 2.28672115 |
| 73 | Retinal dysplasia (HP:0007973) | 2.27947663 |
| 74 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.27320834 |
| 75 | Sclerocornea (HP:0000647) | 2.26277527 |
| 76 | * Postaxial hand polydactyly (HP:0001162) | 2.26269220 |
| 77 | Mutism (HP:0002300) | 2.25870450 |
| 78 | Absent speech (HP:0001344) | 2.24684930 |
| 79 | Excessive salivation (HP:0003781) | 2.22423233 |
| 80 | Drooling (HP:0002307) | 2.22423233 |
| 81 | Abnormality of the corticospinal tract (HP:0002492) | 2.22011850 |
| 82 | Pigmentary retinal degeneration (HP:0001146) | 2.21768404 |
| 83 | Chorioretinal atrophy (HP:0000533) | 2.21699200 |
| 84 | Choroideremia (HP:0001139) | 2.20260711 |
| 85 | Tubulointerstitial nephritis (HP:0001970) | 2.18556700 |
| 86 | Male infertility (HP:0003251) | 2.17714448 |
| 87 | * Poor coordination (HP:0002370) | 2.15231691 |
| 88 | * Congenital primary aphakia (HP:0007707) | 2.13699405 |
| 89 | Megalencephaly (HP:0001355) | 2.13630637 |
| 90 | Bell-shaped thorax (HP:0001591) | 2.12476327 |
| 91 | Abolished electroretinogram (ERG) (HP:0000550) | 2.11588766 |
| 92 | Impaired social interactions (HP:0000735) | 2.11100453 |
| 93 | Abnormal social behavior (HP:0012433) | 2.11100453 |
| 94 | Turricephaly (HP:0000262) | 2.10549359 |
| 95 | Male pseudohermaphroditism (HP:0000037) | 2.10226091 |
| 96 | * Medial flaring of the eyebrow (HP:0010747) | 2.10095676 |
| 97 | Amblyopia (HP:0000646) | 2.09086524 |
| 98 | Stage 5 chronic kidney disease (HP:0003774) | 2.07170770 |
| 99 | Spastic gait (HP:0002064) | 2.06884326 |
| 100 | Type II diabetes mellitus (HP:0005978) | 2.06028825 |
| 101 | Rhinitis (HP:0012384) | 2.05123198 |
| 102 | Insomnia (HP:0100785) | 2.04863030 |
| 103 | Epileptiform EEG discharges (HP:0011182) | 2.04663801 |
| 104 | Postural instability (HP:0002172) | 2.03461284 |
| 105 | Anencephaly (HP:0002323) | 2.02331074 |
| 106 | Diplopia (HP:0000651) | 2.00971562 |
| 107 | Abnormality of binocular vision (HP:0011514) | 2.00971562 |
| 108 | Stereotypic behavior (HP:0000733) | 2.00327130 |
| 109 | Abnormal eating behavior (HP:0100738) | 2.00247053 |
| 110 | EEG with generalized epileptiform discharges (HP:0011198) | 1.99294640 |
| 111 | * Genital tract atresia (HP:0001827) | 1.97601342 |
| 112 | Intention tremor (HP:0002080) | 1.96792116 |
| 113 | Abnormal urine output (HP:0012590) | 1.95448479 |
| 114 | Aplasia involving bones of the extremities (HP:0009825) | 1.95008799 |
| 115 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.95008799 |
| 116 | Aplasia of the phalanges of the hand (HP:0009802) | 1.95008799 |
| 117 | * Vaginal atresia (HP:0000148) | 1.93537740 |
| 118 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.93308830 |
| 119 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.93308830 |
| 120 | Abnormality of the renal cortex (HP:0011035) | 1.91481746 |
| 121 | Hypsarrhythmia (HP:0002521) | 1.88041383 |
| 122 | Lower limb muscle weakness (HP:0007340) | 1.87235611 |
| 123 | Attenuation of retinal blood vessels (HP:0007843) | 1.87111484 |
| 124 | Urinary urgency (HP:0000012) | 1.86522035 |
| 125 | Papilledema (HP:0001085) | 1.86288799 |
| 126 | * Nephrogenic diabetes insipidus (HP:0009806) | 1.85614847 |
| 127 | Preaxial hand polydactyly (HP:0001177) | 1.85434750 |
| 128 | Abnormality of the aortic arch (HP:0012303) | 1.84532178 |
| 129 | Vitreoretinal degeneration (HP:0000655) | 1.83100647 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82527057 |
| 131 | Sleep apnea (HP:0010535) | 1.81899495 |
| 132 | Narrow forehead (HP:0000341) | 1.81385991 |
| 133 | * Aplasia/Hypoplasia of the lens (HP:0008063) | 1.80479701 |
| 134 | Photophobia (HP:0000613) | 1.79586214 |
| 135 | Renal salt wasting (HP:0000127) | 1.79273827 |
| 136 | Scanning speech (HP:0002168) | 1.78501390 |
| 137 | Bradykinesia (HP:0002067) | 1.78077925 |
| 138 | * Specific learning disability (HP:0001328) | 1.77922777 |
| 139 | Atelectasis (HP:0100750) | 1.77687849 |
| 140 | Blue irides (HP:0000635) | 1.76783581 |
| 141 | Abnormality of the lower motor neuron (HP:0002366) | 1.76075036 |
| 142 | Renal dysplasia (HP:0000110) | 1.75595230 |
| 143 | Tubulointerstitial abnormality (HP:0001969) | 1.73491575 |
| 144 | Nasal polyposis (HP:0100582) | 1.73404703 |
| 145 | Hyperaldosteronism (HP:0000859) | 1.73170540 |
| 146 | Abnormal biliary tract physiology (HP:0012439) | 1.70772233 |
| 147 | Bile duct proliferation (HP:0001408) | 1.70772233 |
| 148 | Hypokalemic alkalosis (HP:0001949) | 1.70108156 |
| 149 | Abnormality of renal excretion (HP:0011036) | 1.69881933 |
| 150 | * Broad foot (HP:0001769) | 1.69583519 |
| 151 | Neoplasm of the heart (HP:0100544) | 1.64957556 |
| 152 | Increased corneal curvature (HP:0100692) | 1.64785328 |
| 153 | Keratoconus (HP:0000563) | 1.64785328 |
| 154 | Bronchomalacia (HP:0002780) | 1.63378602 |
| 155 | Cerebellar dysplasia (HP:0007033) | 1.62716872 |
| 156 | * Decreased testicular size (HP:0008734) | 1.61827368 |
| 157 | Congenital malformation of the right heart (HP:0011723) | 1.57714293 |
| 158 | Double outlet right ventricle (HP:0001719) | 1.57714293 |
| 159 | * Left ventricular hypertrophy (HP:0001712) | 1.55245371 |
| 160 | * Prominent nasal bridge (HP:0000426) | 1.54396530 |
| 161 | * Retinitis pigmentosa (HP:0000510) | 1.52925574 |
| 162 | Increased circulating renin level (HP:0000848) | 1.51942233 |
| 163 | Bifid tongue (HP:0010297) | 1.51503041 |
| 164 | * Short foot (HP:0001773) | 1.49542119 |
| 165 | Hyperactive renin-angiotensin system (HP:0000841) | 1.48949536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.21348634 |
| 2 | EPHA4 | 4.18629926 |
| 3 | PNCK | 3.41168904 |
| 4 | MAP3K9 | 3.38681862 |
| 5 | MAPK15 | 3.18045200 |
| 6 | MARK1 | 2.93244254 |
| 7 | MAP3K4 | 2.71459038 |
| 8 | PRKD3 | 2.44684152 |
| 9 | NTRK2 | 2.36405923 |
| 10 | MAP4K2 | 2.35145112 |
| 11 | MAP2K4 | 2.29667754 |
| 12 | PAK6 | 2.19105255 |
| 13 | MINK1 | 2.17501480 |
| 14 | MAP2K7 | 2.13686581 |
| 15 | FRK | 1.96509713 |
| 16 | DAPK2 | 1.88120935 |
| 17 | TNIK | 1.81681017 |
| 18 | CASK | 1.67339433 |
| 19 | CAMK1G | 1.59706792 |
| 20 | CAMKK1 | 1.57645173 |
| 21 | NTRK1 | 1.52691443 |
| 22 | SIK2 | 1.52256498 |
| 23 | CDK5 | 1.47997179 |
| 24 | BMPR1B | 1.47024556 |
| 25 | TYRO3 | 1.43570738 |
| 26 | EPHA3 | 1.37463762 |
| 27 | MAPK13 | 1.36244783 |
| 28 | STK38 | 1.35571513 |
| 29 | KSR2 | 1.34327443 |
| 30 | KSR1 | 1.33309789 |
| 31 | PLK2 | 1.31124673 |
| 32 | PRPF4B | 1.27267481 |
| 33 | MAP3K12 | 1.25572639 |
| 34 | RIPK4 | 1.21494759 |
| 35 | GRK5 | 1.20537863 |
| 36 | FES | 1.17692568 |
| 37 | UHMK1 | 1.16398902 |
| 38 | BCKDK | 1.13783281 |
| 39 | SGK494 | 1.13326887 |
| 40 | SGK223 | 1.13326887 |
| 41 | DYRK2 | 1.11336767 |
| 42 | LATS1 | 1.11181526 |
| 43 | PRKCG | 1.09424789 |
| 44 | EPHB2 | 1.05015080 |
| 45 | NME1 | 1.03737397 |
| 46 | TNK2 | 1.02585517 |
| 47 | ERBB2 | 1.00471266 |
| 48 | DYRK1B | 0.99572274 |
| 49 | ICK | 0.98651559 |
| 50 | GRK1 | 0.98537155 |
| 51 | OXSR1 | 0.98367258 |
| 52 | PAK3 | 0.97982765 |
| 53 | MAP3K7 | 0.97721706 |
| 54 | PKN1 | 0.97086578 |
| 55 | STK39 | 0.96857893 |
| 56 | FER | 0.95221726 |
| 57 | ADRBK2 | 0.93910266 |
| 58 | SGK2 | 0.93445762 |
| 59 | STK38L | 0.92657779 |
| 60 | CSNK1G3 | 0.92256963 |
| 61 | WNK3 | 0.91706924 |
| 62 | CAMK2A | 0.90961444 |
| 63 | PHKG2 | 0.89011410 |
| 64 | PHKG1 | 0.89011410 |
| 65 | CSNK1A1L | 0.85873823 |
| 66 | DAPK1 | 0.85107782 |
| 67 | WNK1 | 0.85071909 |
| 68 | MAP3K2 | 0.84704719 |
| 69 | DYRK1A | 0.81880170 |
| 70 | CAMK1D | 0.81494298 |
| 71 | PTK2B | 0.80927886 |
| 72 | CAMK1 | 0.79372364 |
| 73 | MARK2 | 0.77158266 |
| 74 | WNK4 | 0.75883034 |
| 75 | AKT3 | 0.75707671 |
| 76 | SGK1 | 0.75334151 |
| 77 | CDK19 | 0.75212159 |
| 78 | PRKAA1 | 0.75107740 |
| 79 | CDK18 | 0.74824683 |
| 80 | PRKCH | 0.73911126 |
| 81 | CDK15 | 0.73819443 |
| 82 | PINK1 | 0.72434017 |
| 83 | LATS2 | 0.72300018 |
| 84 | CAMK2B | 0.71934314 |
| 85 | NEK6 | 0.71706926 |
| 86 | CDK14 | 0.71647924 |
| 87 | SGK3 | 0.71480330 |
| 88 | PDK4 | 0.69772309 |
| 89 | PDK3 | 0.69772309 |
| 90 | STK11 | 0.69043575 |
| 91 | BMPR2 | 0.63950931 |
| 92 | MAP2K6 | 0.63733310 |
| 93 | MAPK12 | 0.63417014 |
| 94 | CDK11A | 0.63035490 |
| 95 | CSNK1G1 | 0.62682434 |
| 96 | ERBB3 | 0.61225872 |
| 97 | MUSK | 0.60827833 |
| 98 | FGFR2 | 0.60385560 |
| 99 | MAP3K13 | 0.60330298 |
| 100 | CAMK2G | 0.57936530 |
| 101 | RPS6KA4 | 0.57878398 |
| 102 | BCR | 0.57743530 |
| 103 | CAMKK2 | 0.56681997 |
| 104 | MAPK10 | 0.54488108 |
| 105 | PRKCZ | 0.54250250 |
| 106 | CSNK1A1 | 0.54152110 |
| 107 | CSNK1G2 | 0.53657908 |
| 108 | RPS6KA3 | 0.53425678 |
| 109 | CAMK4 | 0.53355830 |
| 110 | LMTK2 | 0.52868905 |
| 111 | RIPK1 | 0.52674527 |
| 112 | FLT3 | 0.52458435 |
| 113 | PRKCE | 0.52382273 |
| 114 | CAMK2D | 0.52351199 |
| 115 | ARAF | 0.52124253 |
| 116 | IRAK2 | 0.51399008 |
| 117 | PRKACA | 0.49761895 |
| 118 | CDC42BPA | 0.49333311 |
| 119 | PRKD2 | 0.48909397 |
| 120 | MAPKAPK3 | 0.48907754 |
| 121 | RET | 0.47382675 |
| 122 | TAOK1 | 0.46442118 |
| 123 | FGR | 0.46355227 |
| 124 | ADRBK1 | 0.44112748 |
| 125 | EIF2AK2 | 0.43260425 |
| 126 | RPS6KA2 | 0.43149062 |
| 127 | ALK | 0.40748144 |
| 128 | MAPKAPK5 | 0.40580654 |
| 129 | PRKCB | 0.40250616 |
| 130 | PDK1 | 0.38679644 |
| 131 | SIK3 | 0.37801429 |
| 132 | FYN | 0.37661452 |
| 133 | TIE1 | 0.37428037 |
| 134 | INSRR | 0.37221966 |
| 135 | DDR2 | 0.36382977 |
| 136 | ROCK1 | 0.36171041 |
| 137 | CSNK1D | 0.36018479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.93594978 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.59185954 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.08351055 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.84601483 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67802436 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.62412600 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.57428080 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50109607 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.44242013 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.41833472 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.31440251 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14795504 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.07047003 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99625283 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.96513701 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94591191 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.91363709 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.87116019 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84018556 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.78143032 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67810508 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65902679 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.62486347 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.60220840 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58970780 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.53793417 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53629238 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49372679 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49014453 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44656543 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.41653894 |
| 32 | Axon guidance_Homo sapiens_hsa04360 | 1.33531975 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33264209 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32713430 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32636932 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30853401 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28473964 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26729551 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18408101 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16469667 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15947729 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.13913648 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13150734 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11233175 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10732412 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.10707728 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.09513895 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08390433 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08170237 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07989445 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07599153 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07338098 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 1.06919145 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06270026 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.02077140 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99435257 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98073092 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97896416 |
| 59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96265549 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94955193 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94091962 |
| 62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91577115 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91413639 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89971735 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86392995 |
| 66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85469162 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84766151 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84679063 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83407988 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82912389 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80788008 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79729737 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79693065 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79628218 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78861866 |
| 76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78313098 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.76747463 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75969619 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74544544 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73905156 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73279436 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72795687 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72759331 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72207670 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71470988 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70010604 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69789230 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68576147 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.66365689 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65395724 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.64544493 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63388467 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63386582 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63047491 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61951166 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61769266 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61749282 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61064775 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.60312764 |
| 100 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59695789 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59049929 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56818524 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56795665 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55119688 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54928592 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53951090 |
| 107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53921539 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52795901 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52707660 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51227403 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50002650 |
| 112 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49980750 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49559604 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49199393 |
| 115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48624534 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48258328 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47968453 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47736315 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47149019 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46813162 |
| 121 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46514478 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45967842 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44723915 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44177166 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42557374 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41403092 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.41182287 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39106056 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37818003 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37006155 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36436673 |
| 132 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.35269759 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.34764387 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34180505 |
| 135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33173707 |
| 136 | Bile secretion_Homo sapiens_hsa04976 | 0.32993319 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31142826 |
| 138 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29768355 |
| 139 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26804858 |
| 140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26379683 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.25084665 |
| 142 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22857099 |
| 143 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22117741 |

